The global portal hypertension management market is projected to witness substantial growth, reaching a value of US$ 4.97 billion by 2033, according to a recent report released by Future Market Insights. The report forecasts the market to reach US$ 3.05 billion in 2023, with a compound annual growth rate (CAGR) of 5% from 2023 to 2033.
Portal hypertension, a condition characterized by high blood pressure in the portal venous system, presents a spectrum of diagnoses including beta-blockers, somatostatin and its analogues, and vasopressin and its analogues. Currently, the generic pharmaceutical segment dominates the market, indicating significant potential for research and development in the medical field.
Our Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16585
Cirrhosis, a liver disease caused by scar tissue replacing healthy liver cells, stands as one of the primary causes of portal hypertension. The prevalence of cirrhosis, particularly among males, is expected to be a key driver for market expansion. According to the National Institute of Diabetes and Digestive and Kidney Diseases, the aging population is anticipated to further contribute to the market growth.
“The increasing incidence of cirrhosis, coupled with the aging population, is driving the demand for effective portal hypertension management solutions,” said a spokesperson from Future Market Insights. “This presents lucrative opportunities for market players to innovate and develop advanced therapeutic approaches.”
The report highlights the importance of addressing the unmet medical needs in portal hypertension management and emphasizes the significance of continued research and development efforts in the pharmaceutical industry.
Key Takeaways from the Market Study:
- From 2018 to 2022, sales witnessed major growth, registering a CAGR of 3%
- The global portal hypertension management market is predicted to garner a market value of US$ 97 Billion.
- Portal hypertension management market in North America is expected to grow at a CAGR of 4%
- Endoscopic therapy to be most preferred, expected to grow at a CAGR of 7%.
- The Asia Pacific market is expected to account for 40% of the market share.
“The therapies under advancement are focused on novel approaches to treating/improving disease signs. Companies involved are working on developing Portal Hypertension therapies. The launch of new treatments will have a significant impact on the portal hypertension management market.” says FMI’s analyst.
Methodology Details Just a Click Away: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-16585
Competitive Landscape:
Key players in the Portal Hypertension Management market are Ono Pharmaceutical Co., Ltd., Chiasma, Inc., Genextra S.p.a., Gilead Sciences, Inc., Debiovision, Inc., Govind Ballabh Pant Hospital, Dr. Falk Pharma GmbH, Novartis AG, Sun Pharmaceuticals Industries Ltd. Some recent developments by manufacturers are below
- In August 2022, ONO received approval in Japan for Onoact® for Intravenous Infusion 50mg/150mg (“Onoact”), a short-acting selective 1 blocker.
- In March 2021, Gilead Sciences announced that it would expand its collaboration with Novo Nordisk and gain knowledge of the prospects for composite strategies in helping patients with cirrhosis caused by NASH, contributing to the portal hypertension management market.
Key Segments Profiled in the Portal Hypertension Management Industry Survey:
By Treatment:
- Liver Transplantation
- Endoscopic Therapy
- Banding
- Balloon Tamponade
- Shunting Procedures
- Nonsurgical Transjugular Intrahepatic Portal Systemic Shunt
- Surgical Shun
- Drug Class
- Octapeptides
- Cofactors
- PDE5 Inhibitor
- Beta Blockers
By End Users:
- Hospitals
- Specialty Clinic
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Get a Purchase on the Report: https://www.futuremarketinsights.com/checkout/16585
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
